Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Deans

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
DNA Repair|June 15, 2024
FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repairLara Abbouche, Rohan Bythell-Douglas, Andrew J Deans
NPJ Breast Cancer|September 29, 2021
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancerPaolo Peterlongo, Gisella Figlioli, Andrew J Deans, et al.
Frontiers in Cell and Developmental Biology|March 3, 2020
ATR-Mediated FANCI Phosphorylation Regulates Both Ubiquitination and Deubiquitination of FANCD2Winnie Tan, Sylvie van Twest, Vincent J Murphy, et al.
Molecular Cell|May 13, 2021
The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer targetMichael F Sharp, Rohan Bythell-Douglas, Andrew J Deans, et al.
Nucleus (Austin, Tex.)|October 31, 2019
ALT control, delete: FANCM as an anti-cancer target in Alternative Lengthening of TelomeresJulienne J O'Rourke, Rohan Bythell-Douglas, Elyse A Dunn, et al.
The International Journal of Developmental Biology|October 8, 2004
MMTV-trBrca1 mice display strain-dependent abnormalities in vaginal developmentKaylene J Simpson, Mas R Wati, Andrew J Deans, et al.
Oncogene|June 23, 2004
Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary glandAndrew J Deans, Kaylene J Simpson, Melanie K Trivett, et al.
Human Molecular Genetics|January 27, 2012
The DNA translocase activity of FANCM protects stalled replication forksAndrew N Blackford, Rebekka A Schwab, Jadwiga Nieminuszczy, et al.
Cancer Research|August 17, 2006
Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancersAndrew J Deans, Kum Kum Khanna, Carolyn J McNees, et al.
DNA Repair|June 27, 2017
ASCIZ/ATMIN is dispensable for ATM signaling in response to replication stressRui Liu, Ashleigh King, Nicolas C Hoch, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
DNA Repair|June 15, 2024
FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repairLara Abbouche, Rohan Bythell-Douglas, Andrew J Deans
NPJ Breast Cancer|September 29, 2021
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancerPaolo Peterlongo, Gisella Figlioli, Andrew J Deans, et al.
Frontiers in Cell and Developmental Biology|March 3, 2020
ATR-Mediated FANCI Phosphorylation Regulates Both Ubiquitination and Deubiquitination of FANCD2Winnie Tan, Sylvie van Twest, Vincent J Murphy, et al.
Molecular Cell|May 13, 2021
The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer targetMichael F Sharp, Rohan Bythell-Douglas, Andrew J Deans, et al.
Nucleus (Austin, Tex.)|October 31, 2019
ALT control, delete: FANCM as an anti-cancer target in Alternative Lengthening of TelomeresJulienne J O'Rourke, Rohan Bythell-Douglas, Elyse A Dunn, et al.
The International Journal of Developmental Biology|October 8, 2004
MMTV-trBrca1 mice display strain-dependent abnormalities in vaginal developmentKaylene J Simpson, Mas R Wati, Andrew J Deans, et al.
Oncogene|June 23, 2004
Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary glandAndrew J Deans, Kaylene J Simpson, Melanie K Trivett, et al.
Human Molecular Genetics|January 27, 2012
The DNA translocase activity of FANCM protects stalled replication forksAndrew N Blackford, Rebekka A Schwab, Jadwiga Nieminuszczy, et al.
Cancer Research|August 17, 2006
Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancersAndrew J Deans, Kum Kum Khanna, Carolyn J McNees, et al.
DNA Repair|June 27, 2017
ASCIZ/ATMIN is dispensable for ATM signaling in response to replication stressRui Liu, Ashleigh King, Nicolas C Hoch, et al.
Pageof 6